GT Biopharma (GTBP) Non Operating Interest Expenses (2010 - 2026)
GT Biopharma's (GTBP) quarterly Non Operating Interest Expenses came in at $63000.0 in Q1 2026, up 6200.0% quarter-over-quarter from $1000.0 in Q2 2023.
Powered by 
Analysis
GT Biopharma (GTBP) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
GT Biopharma (GTBP) has reported Non Operating Interest Expenses for 14 consecutive years, with $63000.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Non Operating Interest Expenses changed N/A year-over-year to $63000.0 in Q1 2026; TTM through Mar 2026 was $64000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $127000.0, changed N/A from the prior year.
- Non Operating Interest Expenses was $63000.0 for Q1 2026 at GT Biopharma, up from $1000.0 in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $212000.0 in Q1 2023 and troughed at $1000.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 673.00 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 247.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 11.00 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | -1.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 20.27 Mn |
| 10 | GT Biopharma | 337,746.23 | 337,746.23 | - | 63,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 212,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Jun 30, 2021 | 480,000.00 |
| Mar 31, 2021 | 696,000.00 |
| Dec 31, 2020 | -9.23 Mn |
| Sep 30, 2020 | 931,000.00 |
| Jun 30, 2020 | 15.86 Mn |
| Mar 31, 2020 | 638,000.00 |
| Dec 31, 2019 | -3.62 Mn |
| Sep 30, 2019 | 560,000.00 |
| Jun 30, 2019 | 479,000.00 |
| Mar 31, 2019 | 454,000.00 |
| Dec 31, 2018 | 1.14 Mn |
| Sep 30, 2018 | 1.12 Mn |
| Jun 30, 2018 | 3.92 Mn |
| Mar 31, 2018 | 2.93 Mn |
| Dec 31, 2017 | 135,000.00 |
| Sep 30, 2017 | 3.77 Mn |